BIO Protocol facilitates a global collaboration among scientists, patients, and investors to jointly fund, develop, and co-own innovative drugs and therapies via its network of Biotech Decentralized Autonomous Organizations (BioDAOs). This protocol's groundbreaking model addresses significant deficiencies in conventional scientific funding, especially in critical areas like rare diseases, longevity research, and emerging health issues. The BIO token serves as the cornerstone of the decentralized science (DeSci) economy, functioning as a governance token that allows holders to express support for specific BioDAOs and gain preferred access to their initial funding rounds.